# Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice.
**SUMMARY:**
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
**FOR FURTHER INFORMATION CONTACT:**
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, *[email protected]* .
**SUPPLEMENTARY INFORMATION:**
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at *https://www.reginfo.gov/public/do/PRAMain* . An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
| Title of collection | OMB | Date approval expires |
| --- | --- | --- |
| Temporary Marketing Permit Applications | 0910-0133 | 11/30/2020 |
| Establishing and Maintaining Lists of U.S. Milk Product Manufacturers/Processors with Interest in Exporting | 0910-0509 | 11/30/2020 |
| Channels of Trade Policy for Commodities with Residues of Pesticide Chemicals for Which Tolerances Have been Revoked, Suspended, or Modified by the EPA | 0910-0562 | 11/30/2020 |
| Medical Devices; Exception from General Requirements for Informed Consent | 0910-0586 | 11/30/2020 |
| Exceptions or Alternatives to Labeling Requirements for Products Held by the Strategic National Stockpile | 0910-0614 | 11/30/2020 |
| Prescription Drug Advertisements | 0910-0686 | 11/30/2020 |
| Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded | 0910-0688 | 11/30/2020 |
| Electronic Submission of Allegations of Regulatory Misconduct Associated with Medical Devices | 0910-0769 | 11/30/2020 |
| Providing Waiver-Related Materials in Accordance With the Guidance for Industry on Providing Post-Market Periodic Safety Reports in the International Conference on Harmonisation E2C(R2) Format | 0910-0771 | 11/30/2020 |
| Data To Support Social and Behavioral Research as Used by the Food and Drug Administration | 0910-0847 | 11/30/2020 |
Dated: February 9, 2018.
Leslie Kux,
Associate Commissioner for Policy.